The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
I had a great experience and met high profile professionals.
Antonio Menegatti
Politecnico di Milano, Italy
Excellent professional gathering, perfect collection of topics and very up-to-date insight.
Ludovic Urgeghe
University of Mons, Belgium
One very long and hard day, but very useful for my work in TTO.
Petr Kubečka
Palacký University Olomouc, Czech Republic
The course exceeded my expectations. We exchanged experiences and learned different options of approaches to existing problems.
Patricia Lima
Instituto Superior Technico, Portugal
International presence is amazing, so many countries, universities... represented here!!
Christian Massus
SATT Aquitaine, France
Join our newsletter and get the latest news